Results 21 to 30 of about 59,789 (242)

Methemoglobinemia and acute hemolysis induced by high intravenous doses of vitamin C in a COVID-19 patient with unrecognized glucose-6- phosphate-dehydrogenase deficiency

open access: yesGeriatric Care, 2022
In glucose-6-phosphate-dehydrogenase deficiency (favism), exposure to oxidant agents can trigger hemolytic crises. The intravenous administration of very high doses of vitamin C was proposed as a treatment for severe coronavirus disease 2019 (COVID-19 ...
Filippo Luca Fimognari   +6 more
doaj   +1 more source

The relationship between COVID-19 and blood vitamin C; a systematic review study [PDF]

open access: yesJournal of Preventive Epidemiology, 2021
Introduction: The rapid worldwide spread of COVID-19 has caused a global health crisis. Unfortunately, no vaccine or special antiviral drug has been developed against COVID-19 to date, symptomatic supportive care has been the most common treatment ...
Sadeq Hosseinpour   +7 more
doaj   +1 more source

Treatment of pancreatic cancer with intravenous vitamin C [PDF]

open access: yesAnti-Cancer Drugs, 2018
Pancreatic ductal adenocarcinoma (PDA) has a dismal prognosis and is often discovered at an advanced stage with few therapeutic options. Current conventional regimens for PDA are associated with significant morbidity, decreased quality of life, and a considerable financial burden.
Drisko, Jeanne A.   +4 more
openaire   +2 more sources

Vitamin C Intervention for Critical COVID-19: A Pragmatic Review of the Current Level of Evidence

open access: yesLife, 2021
Severe respiratory infections are characterized by elevated inflammation and generation of reactive oxygen species (ROS) which may lead to a decrease in antioxidants such as vitamin C and a higher requirement for the vitamin.
Patrick Holford   +3 more
doaj   +1 more source

Effect of intravenous Vitamin C on sleep quality in hemodialysis patients

open access: yesمجله دانشگاه علوم پزشکی گرگان, 2011
Background and Objective: Poor sleep quality is common among hemodialysis patients and can potentially predict morbidity, mortality and quality of life in these patients. On the other hand, hemodialysis patients are encountered with vitamin C deficiency.
Espahbodi F (MD)   +3 more
doaj   +1 more source

Chemical reactions of vitamin C with intravenous-iron formulations [PDF]

open access: yesNephrology Dialysis Transplantation, 2007
Intravenous (IV) iron is widely prescribed for patients on haemodialysis, to replace iron losses during treatment. It releases labile iron, which can induce oxidation of vitamin C and trigger oxidant damage. We examined the stability of vitamin C in the presence of IV iron compounds.
Suxin, Wang   +4 more
openaire   +2 more sources

Early high-dose vitamin C in post-cardiac arrest syndrome (VITaCCA): study protocol for a randomized, double-blind, multi-center, placebo-controlled trial

open access: yesTrials, 2021
Background High-dose intravenous vitamin C directly scavenges and decreases the production of harmful reactive oxygen species (ROS) generated during ischemia/reperfusion after a cardiac arrest.
Sander Rozemeijer   +13 more
doaj   +1 more source

Ascorbic acid concentrations in aqueous humor after systemic vitamin C supplementation in patients with cataract: pilot study

open access: yesBMC Ophthalmology, 2017
Background To measure ascorbic acid concentration in aqueous humor of patients with cataract after oral or intravenous vitamin C supplementation. Methods Forty-two eyes of 42 patients with senile cataract who underwent uncomplicated cataract surgery were
Young-Sool Hah   +7 more
doaj   +1 more source

Evaluation of the effect of high dose intravenous vitamin C on delayed allograft function in deceased donor kidney transplantation: a preliminary report

open access: yesRenal Replacement Therapy, 2020
Background Delayed graft function (DGF) can affect short- and long-term allograft outcomes in kidney transplant recipients. One of the pathophysiological pathways in the occurrence of DGF is ischemia-reperfusion injury (IRI).
Mina Borran   +4 more
doaj   +1 more source

No significant benefit of moderate-dose vitamin C on severe COVID-19 cases

open access: yesOpen Medicine, 2021
There is no specific drug for coronavirus disease 2019 (COVID-19). We aimed to investigate the possible clinical efficacy of moderate-dose vitamin C infusion among inpatients with severe COVID-19.
Zheng Shaoping   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy